Literature DB >> 2198839

Metabolic and endocrine actions of interleukin-1. Effects on insulin-resistant animals.

H O Besedovsky1, A Del Rey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2198839     DOI： 10.1111/j.1749-6632.1990.tb40481.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease.

Authors:  N Yawata; S Nakamura; M Kijima; N Ikai; M Kanai; M Sugita; S Ohno
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.

Authors:  Martijn van Doorn; Michiel Kemme; Margriet Ouwens; Ewoud J van Hoogdalem; Richard Jones; Hans Romijn; Marieke de Kam; Rik Schoemaker; Koos Burggraaf; Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

3.  Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue.

Authors:  Jinghua Bie; Bin Zhao; Jingmei Song; Shobha Ghosh
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

Review 4.  Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization.

Authors:  Shobha Ghosh
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-03

5.  The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.

Authors:  L Serrano-Marco; E Barroso; I El Kochairi; X Palomer; L Michalik; W Wahli; M Vázquez-Carrera
Journal:  Diabetologia       Date:  2011-12-17       Impact factor: 10.122

6.  Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

Authors:  Lucía Serrano-Marco; Ricardo Rodríguez-Calvo; Ilhem El Kochairi; Xavier Palomer; Liliane Michalik; Walter Wahli; Manuel Vázquez-Carrera
Journal:  Diabetes       Date:  2011-05-26       Impact factor: 9.461
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.